Literature DB >> 34623886

Reasons to Consider the COVID-19 Vaccination Status of Patients With Cancer When Analyzing Their COVID-19 Outcomes.

Kazuki Takada1, Shinkichi Takamori1, Naoko Miura1, Yasunori Shikada1, Mototsugu Shimokawa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34623886      PMCID： PMC8659992          DOI： 10.1200/JCO.21.01561

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C).

Authors:  Noha Sharafeldin; Benjamin Bates; Qianqian Song; Vithal Madhira; Yao Yan; Sharlene Dong; Eileen Lee; Nathaniel Kuhrt; Yu Raymond Shao; Feifan Liu; Timothy Bergquist; Justin Guinney; Jing Su; Umit Topaloglu
Journal:  J Clin Oncol       Date:  2021-06-04       Impact factor: 50.717

Review 2.  SARS-CoV-2 vaccines for cancer patients: a call to action.

Authors:  Chiara Corti; Edoardo Crimini; Paolo Tarantino; Gabriella Pravettoni; Alexander M M Eggermont; Suzette Delaloge; Giuseppe Curigliano
Journal:  Eur J Cancer       Date:  2021-02-25       Impact factor: 10.002
  2 in total
  1 in total

1.  Reply to K. Takada et al.

Authors:  Noha Sharafeldin; Benjamin Bates; Qianqian Song; Vithal Madhira; Yu Raymond Shao; Feifan Liu; Timothy Bergquist; Jing Su; Umit Topaloglu
Journal:  J Clin Oncol       Date:  2021-10-08       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.